Showing results (31-40 of 52) with videos related to

Sort By:
Pageof 6
The New England Journal of Medicine|May 10, 1990
Once-daily administration of 2',3'-dideoxyinosine (ddI) in patients with the acquired immunodeficiency syndrome or AIDS-related complex. Results of a Phase I trialT P Cooley, L M Kunches, C A Saunders, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 1, 1993
Longitudinal analysis of responses to oral didanosine therapy following zidovudine therapy in advanced infection with human immunodeficiency virusC McLaren, M Rozencweig, M Beltangady, et al.
American Journal of Epidemiology|July 26, 2000
Randomized controlled trial of audio computer-assisted self-interviewing: utility and acceptability in longitudinal studies. HIVNET Vaccine Preparedness Study Protocol TeamD S Metzger, B Koblin, C Turner, et al.
Blood|December 15, 1992
Effects of therapy with didanosine on hematologic parameters in patients with advanced human immunodeficiency virus diseaseL P Schacter, M Rozencweig, M Beltangady, et al.
International Journal of Cancer|November 20, 2021
Stage at diagnosis and survival among adolescents and young adults with lymphomas following the Affordable Care Act implementation in CaliforniaRenata Abrahão, Julianne J P Cooley, Frances B Maguire, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1992
Impact of bioavailability on determination of the maximal tolerated dose of 2',3'-dideoxyinosine in phase I trialsG L Drusano, G J Yuen, G Morse, et al.
AIDS (London, England)|April 1, 1995
Development of HIV-1 resistance to (-)2'-deoxy-3'-thiacytidine in patients with AIDS or advanced AIDS-related complexM A Wainberg, H Salomon, Z Gu, et al.
JCO Oncology Practice|April 22, 2025
Peripheral Neuropathy Incidence in Children, and Adolescents and Young Adults With Cancer and Medicaid Insurance in CaliforniaRenata Abrahão, Julianne J P Cooley, Justine M Kahn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium studyMary Cianfrocca, Timothy P Cooley, Jeannette Y Lee, et al.
The Journal of Infectious Diseases|June 1, 1995
A phase I/II study of 2'-deoxy-3'-thiacytidine (lamivudine) in patients with advanced human immunodeficiency virus infectionJ M Pluda, T P Cooley, J S Montaner, et al.
Pageof 6